CV THERAPEUTICS
CV Therapeutics, Inc. operates as a research-based biopharmaceutical company. The Company researches and manufactures drugs for the treatment of cardiovascular disease and more specifically angina pectoris. CV Therapeutics serves the healthcare industry in the United States. CV Therapeutics developed Ranexa, a drug to treat chronic angina; and Lexiscan, an injection used as a stress agent in cardiovascular procedures. The company was acquired by Gilead Sciences, the maker of H.I.V. drugs Truvada, Viread, and Atriplia, for about $1.4 billion.
CV THERAPEUTICS
Social Links:
Industry:
Biotechnology Health Care Manufacturing Therapeutics
Founded:
1991-01-01
Address:
Palo Alto, California, United States
Country:
United States
Website Url:
http://www.cvt.com
Total Employee:
251+
Status:
Closed
Total Funding:
0
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS Zoom Video Conferencing Zoom Proofpoint NetNames DNS
Similar Organizations
Anthos Therapeutics
Anthos Therapeutics is a biopharmaceutical company that specializes in the treatment of cardiovascular and metabolic diseases.
CCRP Therapeutics
CCRP Therapeutics GmbH is a biopharmaceutical spin-off of Charité's Center for Cardiovascular Research (CCR).
Founder
Investors List
Frazier Healthcare Partners
Frazier Healthcare Partners investment in Funding Round - CV Therapeutics
Official Site Inspections
http://www.cvt.com
- Host name: 64-79-124-206.static.wiline.com
- IP address: 64.79.124.206
- Location: Belmont United States
- Latitude: 37.5136
- Longitude: -122.2916
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94002
